trial · primary record
TAR-200
Urinary Bladder Neoplasms
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 163 |
| Primary completion | 2026-03-31 |
| Primary endpoint | Pathologic Complete Response (pCR) Rate |
| Registry ID | NCT04919512 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:15.097Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04919512
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Tar-200 · compound